2,525
Views
2
CrossRef citations to date
0
Altmetric
Research Paper

Development of new TAK-285 derivatives as potent EGFR/HER2 inhibitors possessing antiproliferative effects against 22RV1 and PC3 prostate carcinoma cell lines

, , , ORCID Icon, , , , , , , & show all
Article: 2202358 | Received 06 Feb 2023, Accepted 07 Apr 2023, Published online: 25 Apr 2023

Reprints and Permissions

This is an open access article distributed under the terms of the Creative Commons CC BY license, which permits unrestricted use, distribution, reproduction in any medium, provided the original work is properly cited.

You are not required to obtain permission to reuse this article in part or whole.